BRÈVE publiée le 31/07/2024 à 19:50, il y a 3 mois 10 jours Le programme Pompa nommé dans le classement Fast 50 Emerging Companies 2024 du Utah Business Magazine Santé Et Bien-être Croissance Des Entreprises Rapide 50 Entreprises Émergentes Magazine Économique De L'Utah
BRÈVE publiée le 31/07/2024 à 19:50, il y a 3 mois 10 jours Pompa Program Named in Utah Business Magazine's 2024 Fast 50 Emerging Companies Business Growth Health And Wellness Emerging Companies Fast 50 Utah Business Magazine
COMMUNIQUÉ DE PRESSE publié le 31/07/2024 à 19:45, il y a 3 mois 10 jours Pompa Program Named as One of Utah Business Magazine's 2024 Fast 50 Emerging Companies Pompa Program named finalist in Utah Business Magazine's Fast 50 Emerging Companies list, recognized for exceptional growth and impact in health and wellness industry Health And Wellness Emerging Companies Fast 50 Pompa Program Utah Business Magazine
BRÈVE publiée le 19/07/2024 à 15:05, il y a 3 mois 22 jours New Insights Into Which Food Ingredients to Avoid Artificial Sweeteners Food Colorants Processed Meats High Fructose Corn Syrup Vegetable Oils
BRÈVE publiée le 19/07/2024 à 15:05, il y a 3 mois 22 jours Nouvelles informations sur les ingrédients alimentaires à éviter Édulcorants Artificiels Colorants Alimentaires Viandes Transformées Sirop De Maïs Riche En Fructose Les Huiles Végétales
COMMUNIQUÉ DE PRESSE publié le 19/07/2024 à 15:00, il y a 3 mois 22 jours New Insights Into Which Food Ingredients to Avoid Dr. Daniel Pompa reveals studies on top 5 toxic food ingredients to avoid, including artificial sweeteners, harmful colorants, processed meats, high fructose corn syrup, and vegetable oils. Learn more at pompaprogram.com Health Risks Dr. Daniel Pompa Pompa Program Toxic Food Ingredients Avoid
BRÈVE publiée le 18/07/2024 à 23:00, il y a 3 mois 22 jours Le Dr Daniel Pompa partage des études qui révèlent la cause principale de l'acné Epigénétique Causes De L'acné Facteurs Génétiques Régulation Hormonale Perturbateurs Endocriniens
BRÈVE publiée le 18/07/2024 à 23:00, il y a 3 mois 22 jours Dr. Daniel Pompa Shares Studies That Reveal the Core Cause of Acne Epigenetics Acne Causes Genetic Factors Hormone Regulation Endocrine Disruptors
COMMUNIQUÉ DE PRESSE publié le 18/07/2024 à 22:55, il y a 3 mois 22 jours New Insights Into What Causes Acne Dr. Daniel Pompa discusses genetic and epigenetic factors in acne development, highlighting immune system regulation and hormone production. Learn more from Pompa Program Dr. Daniel Pompa Pompa Program Acne Causes Genetic Factors Epigenetic Changes
BRÈVE publiée le 09/07/2024 à 19:05, il y a 4 mois 1 jour New Insights Into the Link Between Cellular Health and Unexplained Weight Gain Toxins Cellular Health Weight Gain Hormone Resistance Metabolism
Publié le 08/11/2024 à 18:00, il y a 2 jours 2 heures Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 08/11/2024 à 18:00, il y a 2 jours 2 heures Covivio - Information on total number of voting rights and share capital
Publié le 08/11/2024 à 17:52, il y a 2 jours 2 heures Total number of voting rights and shares making up the share capital at October 31, 2024
Publié le 08/11/2024 à 17:45, il y a 2 jours 2 heures CHARGEURS - Voting rights monthly statement as of October 31st, 2024
Publié le 10/11/2024 à 02:00, il y a 18 heures 10 minutes Spey Resources Corp. enters into Share Exchange Agreement with Antimony Assets and announces Name Change
Publié le 09/11/2024 à 16:30, il y a 1 jour 3 heures New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Publié le 09/11/2024 à 04:00, il y a 1 jour 16 heures Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Publié le 08/11/2024 à 23:05, il y a 1 jour 21 heures Murchison Minerals Announces Non-Brokered Private Placement
Publié le 10/11/2024 à 13:20, il y a 6 heures 49 minutes EQS-Adhoc: Delivery Hero SE decides on the intended IPO of Talabat Holding plc and plans to use proceeds for general corporate purposes and capital structure optimisation
Publié le 08/11/2024 à 18:35, il y a 2 jours 1 heure Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 08/11/2024 à 18:20, il y a 2 jours 1 heure ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Publié le 08/11/2024 à 18:02, il y a 2 jours 2 heures Funding Circle Plc: POS-Transaction in Own Shares
